​

Funding Round

Series A - Zavante Therapeutics

Series A - Zavante Therapeutics

Investment Firm

Overview

Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.

Announced Date

Mar 30, 2016

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Frazier Healthcare Partners

Frazier Healthcare Partners

Frazier Healthcare Partners is a early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Longitude Capital

Longitude Capital

Longitude Capital is a debt and early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

4

Investor Name
Participant InvestorGlobal Source Ventures
Participant InvestorLongitude Capital
Participant InvestorAisling Capital
Participant InvestorFrazier Healthcare Partners

Round Details and Background

Zavante Therapeutics raised $45000000 on 2016-03-30 in Series A

Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2021
Venture Round - Zavante Therapeutics
1-undefined
Sep 01, 2016
Debt Financing - Zavante Therapeutics
1-10.0M
Mar 30, 2016
Series A - Zavante Therapeutics
4-45.0M
Dec 23, 2015
Venture Round - Zavante Therapeutics
1-10.0M

Recent Activity

There is no recent news or activity for this profile.